Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis

Mustafa Efkan Colpan1, Ayhan Attar, Aylin Colpan

  • 1Department of Neurosurgery, School of Medicine, Ankara University, Samanpazari, Ankara, Turkey. efkancolpan@hotmail.com

Insights

Chlamydia pneumoniae infection is linked to atherosclerosis, potentially worsening it. This study found higher rates of previous ischemic events, calcification, and ulceration in patients with C. pneumoniae infection undergoing carotid endarterectomy.

Area of Science:

  • Cardiovascular Research
  • Infectious Diseases
  • Pathology

Background:

  • Chlamydia pneumoniae infection is implicated in atherosclerosis development and progression.
  • Understanding the role of C. pneumoniae in carotid stenosis is crucial for patient management.

Purpose of the Study:

  • To investigate the presence of Chlamydia pneumoniae in patients undergoing carotid endarterectomy.
  • To evaluate the clinical significance of C. pneumoniae infection in carotid stenosis.

Main Methods:

  • A prospective study of 20 carotid stenosis patients (1997-1999).
  • Assessed C. pneumoniae infection via IgA/IgG titers, electron microscopy, and immunocytochemistry.
  • Correlated C. pneumoniae markers with clinical atherosclerosis indicators.

Main Results:

  • Chronic C. pneumoniae infection (IgG positive) found in 45% of patients; no evidence of reinfection (IgA negative).
  • Microbiological tests (immunocytochemistry, electron microscopy) positive in 35% of patients.
  • Significantly higher prevalence of previous ischemic events, calcification, and ulceration in C. pneumoniae-positive patients (p < 0.05).

Conclusions:

  • An association exists between C. pneumoniae infection and atherosclerosis.
  • Positive Chlamydia markers (IgG, microscopy) correlated with increased clinical indicators of atherosclerotic events (PIE, CALCI, U1, U2).
  • Findings support C. pneumoniae's role in exacerbating atherosclerotic processes in carotid stenosis.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...